Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. ENOV
2. AZN
3. MDT
4. BLSM
5. GRMN
6. TXNM
7. AAPL
8. LTGO
9. AON
10. VRSK

Go back to Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.37 --0 (-0%)
Previous Close $9.37    52 Week High $9.23 
Open $9.37    52 Week Low $1.16 
Day High $9.37    P/E N/A 
Day Low $9.37    EPS $-0.30 
Volume 7,302       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.37 --0 (-0%)
Previous Close $9.37    52 Week High $9.23 
Open $9.37    52 Week Low $1.16 
Day High $9.37    P/E N/A 
Day Low $9.37    EPS $-0.30 
Volume 7,302